Direct oral anticoagulants are an effective therapy for left ventricular thrombus formation

31 August 2019 (00:00 - 00:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Francisco Fernandes Gama

Hospital de Santa Cruz, Carnaxide (Portugal)

7 More presentations in this session

Presentation thumbnail

Use of Non-vitamin K antagonist Oral Anticoagulants in a real-world setting: a community pharmacy-based study.

Mr A. Capiau (Ghent, BE)

Abstract Slides Video

Presentation thumbnail

Potential real-world benefits of low-dose rivaroxaban in Chinese stable cardiovascular patients

Associate Professor B. Yan (Hong Kong, CN)

Abstract Slides Video

Presentation thumbnail

Prediction of major bleeding in patients receiving DOACs for venous thromboembolism: a prospective cohort study.

Doctor M. Vedovati (Perugia, IT)

Abstract Slides Video

Presentation thumbnail

Risk of arterial calcification by conventional vitamin K antagonist treatment

Doctor S. Hasific (Odense, DK)

Abstract Slides Video

Presentation thumbnail

Efficacy and safety of uninterrupted periprocedural edoxaban in patients undergoing catheter ablation for atrial fibrillation: Prospective KYU-RABLE study

Professor N. Takahashi (Oita, JP)

Abstract Slides Video

Access the full session

Session thumbnail

Perspectives on anticoagulation across cardiovascular disease

The Event

ESC Congress 2019

31 August - 4 September 2019

You may be interested in

Congress Presentation

State-of-the-art lecture on pharmacotherapy for acute coronary syndromes

Webinar

Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients

Congress Presentation

Direct oral anticoagulants or warfarin in patients with left ventricular thrombus: a meta-analysis of randomized clinical trials

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources